Product Information
RASUVO 20 MG/0.4 ML AUTOINJ is a brand product labeled by Medexus Pharma Inc., priced at $362.2851 per ML under NDC 59137053004. Its NADAC has been published 527 times since Dec 23, 2015.
FDA first approved this application on Jul 10, 2014.
The High Outlier badge above means this manufacturer's average price in the methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/.4mL
Manufacturer
Medexus Pharma Inc.NDC
59137053004
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA205776FDA Approved
7/10/2014
On Market Since
7/10/2014
Pharmacological Classes
Price Statistics
The NADAC for RASUVO 20 MG/0.4 ML AUTOINJ has been published 527 times since Dec 23, 2015, and over the history we have for it it has risen 7.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $362.2851 per ML |
|---|---|
| All-time high | $362.4800 (Sep 16, 2026) |
| All-time low | $270.2125 (Jul 20, 2016) |
| 52-week high | $362.4800 |
| 52-week low | $351.6109 |
| Median price | $310.1811 |
| Average price | $312.2994 |
| Largest weekly change | -19.9% (Jul 20, 2016) |
| Weeks tracked | 527 |
| Tracking since | Dec 23, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Medexus Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methotrexate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Folate Analog Metabolic Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RASUVO 20 MG/0.4 ML AUTOINJ?
The current National Average Drug Acquisition Cost (NADAC) for RASUVO 20 MG/0.4 ML AUTOINJ, manufactured by Medexus Pharma Inc., is $362.2851 per ML (NDC 59137053004), effective Sep 30, 2026.
How has the price of RASUVO 20 MG/0.4 ML AUTOINJ changed over time?
Over the history we have for it, the NADAC for RASUVO 20 MG/0.4 ML AUTOINJ has risen 7.4%. It has been tracked across 527 weekly CMS publications since Dec 23, 2015.
What are the highest and lowest recorded NADAC prices for RASUVO 20 MG/0.4 ML AUTOINJ?
Since Dec 23, 2015, the NADAC for RASUVO 20 MG/0.4 ML AUTOINJ has ranged from a low of $270.2125 (Jul 20, 2016) to a high of $362.4800 (Sep 16, 2026), with a median of $310.1811 per ML.
Are there cheaper alternatives to RASUVO 20 MG/0.4 ML AUTOINJ?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RASUVO 20 MG/0.4 ML AUTOINJ in a comparable dosage form, but none are currently priced below it.
Who manufactures RASUVO 20 MG/0.4 ML AUTOINJ?
RASUVO 20 MG/0.4 ML AUTOINJ (NDC 59137053004) is labeled by Medexus Pharma Inc., and CMS classifies it as a brand product.